Evidence map›Paper›PMID 42319549›Full record

ArticleTransgenic research2026

Mammalian growth factors enhance regeneration in transgenic tomato lines.

Cecile Garchery, Juliette Benejam, Alexia Grau, Justine Gricourt, Esther Pelpoir, Mathilde Causse

Abstract read
PubMed Publisher
In one paragraph

Article in Transgenic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cecile GarcheryINRAE, UR1052 GAFL, 84143, Montfavet, France.
Juliette BenejamINRAE, UR1052 GAFL, 84143, Montfavet, France.
Alexia GrauINRAE, UR1052 GAFL, 84143, Montfavet, France.
Justine GricourtINRAE, UR1052 GAFL, 84143, Montfavet, France.
Esther PelpoirINRAE, UR1052 GAFL, 84143, Montfavet, France.
Mathilde CausseINRAE, UR1052 GAFL, 84143, Montfavet, France. mathilde.causse@inrae.fr.ORCID 0000-0002-0407-4985

Funding

ANR ANR-24-PESV-0001
6 · The paper itself

Abstract

Genome editing technologies are now available for many crop species, greatly enhancing our ability to investigate gene function and transforming the field of plant transgenesis. However, the capacity to regenerate whole plants from cell culture remains a major limiting factor in many crops. Even in species with regeneration potential, certain genotypes remain recalcitrant. The physiological state of plant cells plays a central role in growth and development and is closely associated with kinase-mediated signaling networks. Notably, several defense-related genes activated during cellular repair processes following transgenesis share significant homology with mammalian defense genes. In this study, we evaluated whether supplementation with three mammalian growth factors could enhance regeneration efficiency in tomato. We selected two cytokines and a pro-inflamatory factor showing homology with plant kinase genes. We compared the percentage of transgenic plants generated through CRISPR-Cas9-mediated mutagenesis of four genes involved in sugar and organic acid metabolism across six tomato lines exhibiting varying regeneration capacities. Over three years of transformation experiments, we demonstrated that the addition of mammalian growth factors during transgenesis significantly improved regeneration frequency, particularly in recalcitrant tomato genotypes. Furthermore, growth factor supplementation not only enhanced transformation efficiency in difficult-to-transform lines but also increased the production of stable secondary lines.

Indexed as

Intercellular Signaling Peptides and ProteinsPlants, Genetically ModifiedRegenerationSolanum lycopersicumAnimalsCRISPR-Cas SystemsGene EditingIntercellular Signaling Peptides and ProteinsCytokineMAP-kinaseRegenerationSolanum lycopersicumTransformation

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.